Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 705
Selected: 0
NCT IDTitle
NCT01423916Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT00972426A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients
NCT01095016A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
NCT00046384Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
NCT02042885A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer
NCT02364947A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
NCT01810783Brexpiprazole in Patients With Schizophrenia
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT01076478Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
NCT02085460A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
NCT014518278-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT03661983Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
NCT00002131A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
NCT07759154A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
NCT01291641Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
NCT04407312Cilostazol and Endothelial Progenitor Cell
NCT00043771Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT06628128A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06589505Software as a Medical Device for the Treatment of Patients With PTSD
NCT04649073Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT03287869A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
NCT00317356A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
NCT02964273Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT05542264A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
NCT01000467Pharmacokinetics Study for Probucol
NCT01733134Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)
NCT03150771Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
NCT07173478A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis
NCT01944969Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
NCT00095524Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
NCT00036127Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT01782833Pletaal SR Post Marketing Observational Study
NCT03470233Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB
NCT02183792Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT01337089Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
NCT00841568A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
NCT00942240Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects
NCT04287985Safety and Efficacy Study of VIS649 for IgA Nephropathy
NCT02196506Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
NCT06795399A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure
NCT03828201Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
NCT02722967Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT01702181A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
NCT02538016TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
NCT03386851Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
NCT02697045Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
NCT01299454A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects